| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $115.23 | $23.64 | 387.39% | 217.42x | 54.84x | 14.62x | 17.65x | 1.58x | $106.92M | 0.88% | $705.78M | 6.70 | $12.35B | 1,574.83 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $26.43 | $8.08 | 227.23% | 125.86x | 59.09x | 7.43x | 15.06x | 1.08x | $39.15M | 1.14% | $220.58M | 1.69 | $3.40B | 74.94 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $246.74 | $79.13 | 211.80% | 40.45x | 36.59x | 6.86x | 24.38x | 1.39x | $793.95M | 2.41% | $1.35B | 10.14 | $34.30B | 29.08 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $74.61 | $17.03 | 338.04% | 69.73x | 63.83x | 6.88x | 8.90x | 1.78x | $182.84M | 3.16% | $654.15M | 8.43 | $5.65B | 47.14 | ||
| KRYS | KRYSTAL BIOTECH INC | $332.56 | $82.57 | 302.75% | 40.21x | 42.61x | 22.29x | 7.24x | 2.15x | $257.78M | 2.63% | $1.36B | 46.03 | $9.42B | 40.40 | ||
| RPRX | ROYALTY PHARMA PLC | $58.36 | $35.58 | 64.02% | 31.04x | 10.67x | 10.24x | 3.43x | 0.63x | $2.92B | 11.26% | $9.79B | 21.99 | $41.71B | 35.46 | ||
| VCEL | VERICEL CORP | $40.14 | $7.86 | 410.53% | 83.63x | 71.72x | 6.69x | 5.55x | 2.05x | $61.66M | 3.01% | $370.04M | 7.25 | $2.02B | 45.92 | ||
| HALO | HALOZYME THERAPEUTICS INC | $110.40 | $69.98 | 57.76% | 31.01x | 12.22x | 7.78x | 87.29x | 0.60x | $806.22M | 6.23% | $143.54M | 1.22 | $14.51B | 20.20 | ||
| TGTX | TG THERAPEUTICS INC | $55.78 | $22.05 | 152.99% | 18.11x | 56.13x | 9.89x | 14.13x | 2.02x | $17.39M | 0.22% | $604.08M | 4.26 | $8.81B | 63.26 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.97 | $7.48 | 46.56% | 11.55x | 10.08x | 4.77x | 2.99x | 1.01x | $82.01M | 12.63% | $217.65M | 3.68 | $507.62M | 6.56 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $60.00 | $18.33 | 227.40% | 157.89x | 20.74x | 3.41x | 1.84x | 1.05x | $738.18M | 6.36% | $6.32B | 32.68 | $14.93B | 38.70 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $231.52 | $177.29 | 30.59% | 15.17x | 9.06x | 3.18x | 3.13x | 0.62x | $1.62B | 11.07% | $4.80B | 75.98 | $17.80B | 11.01 | ||
| ADMA | ADMA BIOLOGICS INC | $10.03 | $6.86 | 46.16% | 13.93x | 12.61x | 4.47x | 5.50x | 0.81x | $116.47M | 5.08% | $408.21M | 1.79 | $2.31B | 9.91 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $312.37 | $84.43 | 269.97% | 31.02x | 33.06x | 21.57x | 6.44x | 2.35x | $130.62M | 2.08% | $967.52M | 48.22 | $6.35B | 22.77 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $522.81 | $145.91 | 258.30% | 30.17x | 27.31x | 10.54x | 6.54x | 2.26x | $3.80B | 2.86% | $20.25B | 79.81 | $128.35B | 23.32 | ||
| EXEL | EXELIXIS INC | $58.41 | $29.51 | 97.94% | 17.75x | 17.66x | 6.01x | 7.85x | 1.17x | $1.17B | 8.00% | $1.84B | 7.35 | $14.36B | 13.20 | ||
| MDXG | MIMEDX GROUP INC | $4.66 | $1.25 | 272.18% | 116.50x | -26.87x | 1.94x | 3.14x | 1.26x | $44.50M | 6.46% | $216.00M | 1.46 | $560.61M | 24.58 | ||
| TECH | BIO-TECHNE CORP | $72.47 | $16.01 | 352.53% | 61.94x | 34.88x | 9.30x | 5.39x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.39B | 32.76 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $39.26 | $29.60 | 32.65% | 12.50x | 9.42x | 2.37x | 2.29x | 0.74x | $354.90M | 15.60% | $999.24M | 17.25 | $1.89B | 6.75 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $758.27 | $420.83 | 80.18% | 18.08x | 13.52x | 5.02x | 2.46x | 0.96x | $3.76B | 4.82% | $31.71B | 308.48 | $78.32B | 13.62 | ||
| UTHR | UNITED THERAPEUTICS CORP | $541.89 | $185.50 | 192.12% | 17.92x | 20.28x | 7.32x | 3.63x | 3.29x | $1.09B | 4.73% | $6.40B | 150.24 | $21.44B | 12.79 | ||
| VCYT | VERACYTE INC | $46.04 | $11.53 | 299.18% | 31.97x | 23.67x | 6.55x | 2.67x | 2.68x | $165.99M | 4.51% | $1.39B | 17.36 | $3.44B | 24.63 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.21 | $1.37 | -11.36% | 8.64x | -2.73x | 1.49x | 1.59x | 0.48x | $19.58M | 27.93% | $44.20M | 0.76 | $21.73M | 2.84 | ||
| INCY | INCYTE CORP | $121.35 | $57.93 | 109.46% | 14.94x | 34.23x | 4.18x | 3.88x | 1.68x | $1.92B | 7.90% | $6.34B | 31.66 | $20.65B | 9.98 |